Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03046498 · ClinicalTrials.gov registry record · NA

Addressing Diabetes Together

A NA study of Diabetes, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT03046498 is a NA study of Diabetes that has completed, run by Mayo Clinic. The registered enrollment target is 50 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03046498, a NA study of Diabetes, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Integration of Diabetes Prevention Program (DPP) and Diabetes Self Management Program (DSMP) into WellConnect.

Conditions Studied

Interventions

  • BEHAVIORAL Evidence-Based Program

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-02-02
Est. Completion 2018-03-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT03046498

The ClinicalTrials.gov registry entry for NCT03046498 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Evidence-Based Program is the first listed.

NCT03046498 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03046498 about?

NCT03046498 is a clinical study titled "Addressing Diabetes Together". Integration of Diabetes Prevention Program (DPP) and Diabetes Self Management Program (DSMP) into WellConnect.

What is the current status of trial NCT03046498?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-02-02. Estimated completion is 2018-03-01.

What conditions does trial NCT03046498 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT03046498?

The interventions under investigation include: Evidence-Based Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT03046498?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03046498 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.